Browse by author
Lookup NU author(s): Dr Alex North, John Hammond
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Non-islet cell tumour hypoglycaemia (NICTH) results from paraneoplastic insulin-like growth factor-II (IGF-II) secretion and its potent insulin-like effect. It causes recurrent, often severe, hypoglycaemic episodes, which is detrimental to quality of life. There is limited evidence regarding best supportive care in unresectable tumours. A 76-year-old woman presented with hypoglycaemic collapse. A new diagnosis of unresectable hepatocellular carcinoma (HCC) was made. The IGF-II:IGF-I ratio was 11.0, which confirmed NICTH. The octreoscan showed avid disease. The main problem was symptomatic nocturnal hypoglycaemia. Curative treatment options were not possible in this case and treatment focused on preventing symptomatic hypoglycaemia. Inpatient treatment was with high carbohydrate nasogastric (NG) feeds, prednisolone and somatostatin analogue (octreotide) infusion. Once stabilised, the patient was discharged with NG feeds, prednisolone and a long-acting somatostatin analogue (sandostatin). The patient received successful end-of-life care with her family as per her wishes, without requiring readmission. The treatments were well-tolerated and effective in preventing symptomatic hypoglycaemic episodes. The combination of high carbohydrate NG feed with prednisolone and somatostatin analogues was effective in preventing symptomatic hypoglycaemia. Somatostatin analogues had a useful steroid sparing role. Larger case series are warranted to clarify the management of NICTH patients with placebo-controlled studies to determine the role of somatostatin analogues.
Author(s): North AS, Thakkar RG, James RA, Hammond JS
Publication type: Article
Publication status: Published
Journal: Annals of the Royal College of Surgeons of England
Year: 2022
Volume: 104
Issue: 6
Pages: e180-e182
Print publication date: 06/06/2022
Online publication date: 08/02/2022
Acceptance date: 02/04/2018
ISSN (electronic): 0026-6493
Publisher: Royal College of Surgeons of England
URL: https://doi.org/10.1308/rcsann.2021.0269
DOI: 10.1308/rcsann.2021.0269
PubMed id: 35133207
Altmetrics provided by Altmetric